Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 4Recurrence 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Burkitt Lymphoma 2Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Diseases 1Anemia 1Amyloidosis 1

Interventions

Rituximab 3pirtobrutinib 2Cyclophosphamide 2venetoclax 1tazemetostat 1prednisolone phosphate 1prednisolone acetate 1idelalisib 1fludarabine 1Vincristine 1Prednisolone 1Methylprednisolone 1Methotrexate 1Doxorubicin 1Cytarabine 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has announcements × Lymphoma, B-Cell × Cyclophosphamide × Clear all
NCT01516580 2026-02-09

Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
482 enrolled 1 FDA
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

NCT04245839 2025-11-05

TRANSCEND FL

Celgene

Phase 2 Active not recruiting
276 enrolled 2 FDA
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡